In addition, ceRNA regulatory loops involving miR-17-5p/PD-L1 have been observed in lung cancer and breast cancer to promote tumor progression and immune checkpoint blockades (ICB) resistance44,45. This evidence concerns the gene CD274 and breast cancer.